Mutations in retinoid X receptor that impair heterodimerization with specific nuclear hormone receptor

被引:10
作者
Lee, SK
Lee, B
Lee, JW [1 ]
机构
[1] Chonnam Natl Univ, Ctr Ligand & Transcript, Kwangju 500757, South Korea
[2] Chonnam Natl Univ, Dept Biol, Kwangju 500757, South Korea
[3] Chonnam Natl Univ, Hormone Res Ctr, Kwangju 500757, South Korea
关键词
D O I
10.1074/jbc.M006418200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Retinoid X receptor (RXR) serves as a promiscuous heterodimerization partner for many nuclear receptors through the identity box, a 40-amino acid subregion within the ligand binding domain. In this study, we randomly mutated two specific residues within the human RXR alpha identity box region previously identified as important determinants in heterodimerization (i.e. Ala(416) and Arg(421)). interestingly, most of these mutants still retained wild type interactions with thyroid hormone receptor (TR), retinoic acid receptor, peroxisome proliferator-activated receptor alpha, small heterodimer partner, and constitutive androstane receptor. However, RXR-A416D and R421L were specifically impaired for interactions with TR, whereas RXR-A416K lost both TR and retinoic acid receptor interactions. Accordingly, RXR-A416D did not support T3 transactivation in mammalian cells, whereas RXR-A416K was not supportive of transactivation by retinoids or T3. These results provide a basis upon which to further design mutant RXRs highly selective in heterodimerization, potentially useful tools to probe nuclear receptor function in vivo.
引用
收藏
页码:33522 / 33526
页数:5
相关论文
共 32 条
[1]   Molecular and structural biology of thyroid hormone receptors [J].
Apriletti, JW ;
Ribeiro, RCJ ;
Wagner, RL ;
Feng, W ;
Webb, P ;
Kushner, PJ ;
West, BL ;
Nilsson, S ;
Scanlan, TS ;
Fletterick, RJ ;
Baxter, JD .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 :S2-S11
[2]  
Ausubel FM, 1995, SHORT PROTOCOLS MOL
[3]   GENE-REGULATION BY STEROID-HORMONES [J].
BEATO, M .
CELL, 1989, 56 (03) :335-344
[4]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[5]   A TRANSCRIPTIONAL CO-REPRESSOR THAT INTERACTS WITH NUCLEAR HORMONE RECEPTORS [J].
CHEN, JD ;
EVANS, RM .
NATURE, 1995, 377 (6548) :454-457
[6]   Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR [J].
Choi, HS ;
Chung, MR ;
Tzameli, I ;
Simha, D ;
Lee, YK ;
Seol, W ;
Moore, DD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23565-23571
[7]   Thyroid hormone-mediated enhancement of heterodimer formation between thyroid hormone receptor beta and retinoid X receptor [J].
Collingwood, TN ;
Butler, A ;
Tone, Y ;
CliftonBligh, RJ ;
Parker, MG ;
Chatterjee, VKK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (20) :13060-13065
[8]   DIFFERENTIAL RECOGNITION OF TARGET GENES BY NUCLEAR RECEPTOR MONOMERS, DIMERS, AND HETERODIMERS [J].
GLASS, CK .
ENDOCRINE REVIEWS, 1994, 15 (03) :391-407
[9]   CDI1, A HUMAN G1-PHASE AND S-PHASE PROTEIN PHOSPHATASE THAT ASSOCIATES WITH CDK2 [J].
GYURIS, J ;
GOLEMIS, E ;
CHERTKOV, H ;
BRENT, R .
CELL, 1993, 75 (04) :791-803
[10]   LIGAND-INDEPENDENT REPRESSION BY THE THYROID-HORMONE RECEPTOR-MEDIATED BY A NUCLEAR RECEPTOR CO-REPRESSOR [J].
HORLEIN, AJ ;
NAAR, AM ;
HEINZEL, T ;
TORCHIA, J ;
GLOSS, B ;
KUROKAWA, R ;
RYAN, A ;
KAMEL, Y ;
SODERSTROM, M ;
GLASS, CK ;
ROSENFELD, MG .
NATURE, 1995, 377 (6548) :397-404